Caroline Young, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 379 shares at $2.19 ($849) on 2022-12-05, disclosed to the SEC on 2022-12-23.
Scheduled purchase ($849) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.33 | 20 | $47 | 5.5% |
| 2 | $2.31 | 20 | $46 | 5.4% |
| 3 | $2.19 | 20 | $44 | 5.2% |
| 4 | $2.19 | 20 | $44 | 5.2% |
| 5 | $2.18 | 20 | $44 | 5.1% |
| 6 | $2.19 | 20 |
| $44 |
| 5.2% |
| 7 | $2.15 | 20 | $43 | 5.1% |
| 8 | $2.14 | 20 | $43 | 5.0% |
| 9 | $2.18 | 20 | $44 | 5.1% |
| 10 | $2.21 | 20 | $44 | 5.2% |
| 11 | $2.24 | 20 | $45 | 5.3% |
| 12 | $2.22 | 20 | $44 | 5.2% |
| 13 | $2.21 | 30 | $66 | 7.8% |
| 14 | $2.31 | 109 | $252 | 29.7% |
| Total | $2.24 avg | 379 | $849 | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $404 | — | Filing → |
| CPIX | BUY | 2025-06-06 | $429 | — | Filing → |
| CPIX | BUY | 2025-05-09 | $417 | — | Filing → |